Atlas Trials

Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers.

Clinical trial NCT01229280 · UNKNOWN

Trial details

NCT number
NCT01229280
Sponsor
Center for Clinical Pharmacology Research Bdbeq S.A.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalency
Start date
2010-12-01
Primary completion
2011-01-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.